BioCentury
ARTICLE | Clinical News

SF-1019 dermatology data

January 21, 2008 8:00 AM UTC

In a European trial, subcutaneous injections of SF-1019 promoted wound healing and resolved chronic lesions. The topical formulation also closed a wound that was 5 mm deep. The next phase of the study...